Published June 11, 2009 | Version v1
Journal article

Fast simultaneous detection of K-RAS mutations in colorectal cancer

  • 1. Department of Veterinary Medicine, National Chung Hsiung University, Taichung, Taiwan (China)
  • 2. Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan (China)
  • 3. Department of Laboratory Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan (China)
  • 4. Department of Pathology, Changhua Christian Hospital, Changhua, Taiwan (China)
  • 5. Center for Excellence in Environmental Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan (China)
  • 6. Institute of Clinical Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan (China)

Description

RAS genes acquire the most common somatic gain-of-function mutations in human cancer, and almost all of these mutations are located at codons 12, 13, 61, and 146. We present a method for detecting these K-RAS hotspot mutations in 228 cases of colorectal cancer. The protocol is based on the multiplex amplification of exons 2, 3 and 4 in a single tube, followed by primer extension of the PCR products using various sizes of primers to detect base changes at codons 12, 13, 61 and 146. We compared the clinicopathological data of colorectal cancer patients with the K-RAS mutation status. K-RAS mutation occurred in 36% (83/228) of our colorectal cancer cases. Univariate analysis revealed a significant association between K-RAS mutation at codon 12 of exon 2 and poor 5-year survival (p = 0.023) and lymph node involvement (p = 0.048). Also, K-RAS mutation at codon 13 of exon 2 correlates with the size of the tumor (p = 0.03). Multivariate analysis adjusted for tumor size, histologic grade, and lymph node metastasis also indicated K-RAS mutations at codon 12 and 13 of exon 2 correlate significantly with overall survival (p = 0.002 and 0.025). No association was observed between codon 61 and 146 and clinicopathological features. We demonstrated a simple and fast way to identify K-RAS mutation

Availability note (English)

Available from http://dx.doi.org/10.1186/1471-2407-9-179; Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2702390

Additional details

Publishing Information

Journal Title
BMC Cancer (Online)
Journal Volume
9
Journal Page Range
p. 179
ISSN
1471-2407

INIS

Country of Publication
United Kingdom
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
46092262
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
CODONS; EXONS; GENES; LYMPH NODES; MULTIVARIATE ANALYSIS; NEOPLASMS; PATIENTS; POLYMERASE CHAIN REACTION; TUBES
Descriptors DEC
DISEASES; GENE AMPLIFICATION; LYMPHATIC SYSTEM; MATHEMATICS; STATISTICS

Optional Information

Copyright
Copyright (c)2009 Chang et al
Notes
PMCID: PMC2702390; PUBLISHER-ID: 1471-2407-9-179; PMID: 19515263; OAI: oai:pubmedcentral.nih.gov:2702390; licensee BioMed Central Ltd.